True Health competitors

Healthcare leader with broad experience across multi-site health service operations, laboratories, and life sciences. Early career as a physician, then McKinsey management consultant, followed by two decade career in healthcare general management, most recently CEO for high growth Laboratory Services company. Expertise in multi-site outpatient and physician management, leveraging Health IT, M&A and achieving revenue and profit growth under challenging reimbursement conditions with a passion for building high performing teams that achieve results.

Dr. Schwartz is founding President and former CEO of WESTMED Medical Group (WMG) which was formed in 1996. He is also the former CEO of Optum Practice Partners (OPP) a physician management services company, which was formed in 2011 and acquired by Optum in 2014.Since its founding, the medical group has grown to over 350 physicians as a multi-specialty group practice with 10 locations in Westchester County, New York and Fairfield CT. WMG embraced the triple aim and is proud to have transitioned to value-based care with a successful ACO and strong results for quality efficiency and service. In his medical career, Dr. Schwartz has been committed to improving the health of the community by providing coordinated, efficient, quality patient care. To accomplish this goal, he and WESTMED were early adopters of healthcare IT, collaborating with many innovative IT vendors in the areas of process and system redesign to improve care. OPP has continued to focus on lean ambulatory healthcare transformation. Improvements in both operational and clinical efficiency were achieved with analytically-based work flow redesign facilitated by extensive use of automated rules and tasking engines.At WESTMED , Dr. Schwartz articulated WESTMED’s culture: to be the best place for patients to receive care, the best place for physicians to practice medicine and the best place for employees to work. Medical Specialties: Dr. Schwartz is a hematologist and oncologist with board certification in internal medicine, medical oncology, hematology and blood banking.

Chris Busky, CAE is a Chief Executive Officer at Infectious Diseases Society of America and is based in Arlington, Virginia. He has worked as SVP & COO at Infectious Diseases Society of America; General Ledger Accountant/Controller at Manufactured Housing Institute; and Vice President, Business Operations at Equipment Leasing and Finance Association. Chris attended Frostburg State University and University of Maryland Global Campus.

Hill is a former PayPal senior executive who has experience leading companies at every stage of growth, from founding a company to serving as senior executive in a high-growth public company.

Purpose-driven company and team builder with more than 25 years of life science industry experience including 15+ years as CEO, leading organizations from formation to strategic exit. Proven experience in raising equity and debt capital, and developing strategic plans that result in demonstrable commercial value. Strong track record of negotiating and managing corporate and academic partnerships that drive value-creation, developing effective and aligned executive and operational teams, and recruiting highly-experienced Board of Directors. • “Start to Finish” CEO with experience in all company phases from seed stage to multi-million revenue product commercialization to strategic exit.Responsibility-centered leader who builds cohesive and intellectually aligned executive teams held accountable for collective results. • Proven success in raising multiple rounds of equity and debt capital from venture capital investors, banks, and corporate partners. • Extremely effective in communicating, both internally and externally, the “why” behind an organization’s existence and basis for its success. • Source, negotiate, close, and manage value-creating partnerships with “brand name” academic, pharmaceutical, biotech, and technology companies. • Strong educational foundation and hands-on experience in developing and implementing strategic plans that create value in early and mid-stage stage organizations. • Reputation among board members and employees as a dedicated and inspirational leader with the ability to motivate and maintain teams throughout a company’s lifecycle.• Experience in developing and executing on business models in both rare disease diagnostics and rare disease therapeutics.

Tom Dent has spent his career at the leading edge of health care delivery innovation, developing better ways for people to get high quality care when and where they need it. He has been involved in a variety of healthcare sectors including managing hospitals and leading national and international companies. As a healthcare leader, he has earned an industry reputation for building quality teams and companies with a focus on outcomes and service value and understanding the needs of patients in a complex and changing medical environment. With rapid developments neurology and the global concern over brain health, Dent in 2010 co-founded London-based Re:Cognition Health that brings together multidisciplinary cognitive experts in centers of excellence to provide complex diagnosis, treatment and care management for people and families impacted by cognitive impairment due to brain injury or progressive neurological diseases such as multiple sclerosis or Alzheimer’s. Dent was awarded the Lang Buisson 2013 UK Healthcare Entrepreneur Achievement Award; a unique accomplishment for an American. Dent was CEO of MedTel International, a US and UK diagnostic imaging and outpatient surgery company, and prior to this, was a co-founder and 15 year leader of PhyCor, Inc., the recognized pioneer in the physician practice and physician network management sector. Over his career he has developed occupational health clinics, mobile imaging services and managed hospitals and skilled nursing facilities. Earlier in his career he worked in mergers/acquisitions at Hospital Corporation of America and was a founding board member of Healthcare Realty Trust, a healthcare REIT and continues to serve as a Director of Healthstream, a provider of online training, education and research to healthcare organizations. Dent graduated with a bachelor’s business degree from Mississippi State University and holds a master’s degree from The George Washington University.

Douglas William Wisor is the Chief Executive Officer and President at National Spine & Pain Centers.

Lloyd Sanders joined Epic Sciences as President and Chief Executive Officer in 2019 with more than 20 years of diagnostics and pharmaceutical industry experience, most of it focused on oncology. Prior to joining Epic, he served as president of the oncology segment of Myriad Genetics, overseeing the oncology, urology and dermatology commercial organizations. While at Myriad, he was responsible for the sales, marketing, medical, customer service and laboratory operations for numerous market-leading commercial products, including molecular diagnostics for risk assessment, diagnosis/screening, prognosis and selection of therapies for breast, prostate, colorectal and other cancers. Previously, Mr. Sanders served as chief operating officer at Dey Pharma, a division of Mylan, overseeing sales, marketing and medical affairs, including the EpiPen® flagship brand. Prior to Dey Pharma, he held several leadership positions including responsibility for the commercial growth of a number of oncology products at Sanofi-Synthelabo, subsequently Sanofi-Aventis, where he led the successful restructuring and integration of two companies’ sales forces after the merger. Mr. Sanders started his pharmaceutical career and participated in oncology product launches at Pharmacia (now Pfizer). Mr. Sanders earned a Bachelor’s business degree with an emphasis in marketing from Memphis State University.